Who We Are

At Apellis, we combine courageous science and compassion to develop life-changing medicines for some of the most challenging diseases patients face.

We Advance Courageous Science

Our goal is to transform treatment for a broad range of debilitating diseases by controlling a part of the immune system known as the complement cascade.

With nearly a dozen clinical and pre-clinical programs underway, we believe we have only begun to unlock the potential of targeting C3 across many serious diseases.

We Replace Impossible With How

More than a decade ago in a university lab in Kentucky, a small group of post-doc scientists, including our CEO and CSO, started a biotech company with a scientific approach that challenged conventional thinking.

At the time, targeting C3 was viewed as scientifically difficult, if not impossible by many, but the significant unmet needs of patients inspired our founders’ efforts to follow the science and continue to drive us forward today. With perseverance and passion, we are working to advance our science from an aspiration to a reality.

We Are Apellis

Apellis is formed by people who care, are fearless in the face of a challenge, love the work they do, and continually pursue the highest level of scientific integrity. Each of these values guide every decision we make as we strive toward our vision of being known for our compassion, revolutionary science, and contributions to humankind around the world.


Our Responsibility

We care fiercely about the greater good of society and believe corporate responsibility is foundational to achieving our vision.

We strive to bring transformative medicines to patients, provide an engaging and inclusive workplace for our employees, minimize our impact on the environment, and always demonstrate integrity in our actions.

We recognize that we are early in our journey and there is much work to be done but are committed to becoming a sustainable company that delivers on its vision.

Read our inaugural Environmental, Social, and Governance (ESG) Report.

Apellis Canada

You are now leaving Apellis.ca and being directed to an Apellis site intended for audiences in a different geography. If you continue, the information you are about to access may not comply with Canadian laws and regulations. Marketing authorizations and availability of products may differ between Canada and other countries. You are solely responsible for your interactions with that website.